(Q44852325)

6 December 2017

Aberrant phosphorylation of alpha-synuclein in human Niemann-Pick type C1 disease (English)

1 reference

6 December 2017

1 reference

1 reference

Yuko Saito

1

1 reference

6 December 2017

Kinuko Suzuki

series ordinal

2

1 reference

6 December 2017

Christine M Hulette

series ordinal

3

1 reference

6 December 2017

Shigeo Murayama

series ordinal

4

1 reference

6 December 2017

1 April 2004

1 reference

Journal of Neuropathology & Experimental Neurology

6 December 2017

1 reference

6 December 2017

63

1 reference

6 December 2017

323-328

1 reference

6 December 2017

4

1 reference

Identification of HE1 as the second gene of Niemann-Pick C disease

6 December 2017

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.323

Neurofibrillary tangles in Niemann-Pick disease type C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.323

Frontal lobe atrophy due to a mutation in the cholesterol binding protein HE1/NPC2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.323

Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.323

Lewy body and Alzheimer pathology in a family with the amyloid-beta precursor protein APP717 gene mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.323

Widespread expression of alpha-synuclein and tau immunoreactivity in Hallervorden-Spatz syndrome with protracted clinical course

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.323

Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.323

Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.323

alpha-Synuclein is phosphorylated in synucleinopathy lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.323

Accumulation of phosphorylated alpha-synuclein in aging human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.323

Monoclonal antibody against the polymorphic site distinguishes apolipoprotein E4 from other isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.323

Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.323

Intraneuronal ApoE in human visual cortical areas reflects the staging of Alzheimer disease pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.323

Apolipoprotein E epsilon4 allele and progression of cortical Lewy body pathology in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.323

Dementia with Lewy bodies and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.323

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.323

21 January 2018

Identifiers

DOI

10.1093/JNEN/63.4.323

1 reference

6 December 2017

1 reference